Endra Life Sciences Inc (NDRA) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

NDRA ranks #10070 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

NDRA is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

10 institutions disclose a position in NDRA, but none treat it as a major bet — even Altium Capital Management LLC, its most concentrated holder, allocates just 0.7% of its own portfolio to it.

Altium Capital Management LLC has added to its NDRA position for two straight quarters, increasing it by $80.8K to reach $315.9K today.

NDRA reported a net loss of $5.9M over the trailing twelve months.

• Not yet profitable — net loss of $5.9M over the trailing twelve months
• Revenue declined 100.0% year over year
• Net income improved year over year, from -$8.8M to -$5.9M
• Operating cash flow was negative, using $5.2M in cash
• Current ratio of 1.29x — below the conventional 1.5x liquidity buffer
• Liabilities run 0.71x equity — within a conventional range